Loading
institutionsInstitution
Ludwig Cancer Research
The cancer research institute that shipping magnate Daniel K. Ludwig endowed in 1971 with nearly all of his international holdings; it has spent more than $1.8 billion of its own money on cancer science.
Also called: Ludwig Institute for Cancer ResearchLICR
Overview
Founded in 1971, the Ludwig Institute for Cancer Research is an international not-for-profit that funds and runs its own laboratories rather than making grants from donations. Its own account states that it has invested more than $1.8 billion of its resources in cancer research and holds an endowment valued at $1.5 billion. In 2006 the Ludwig gift also created Ludwig Centers and professorships at six leading US institutions, each with more than $2 million a year in perpetuity. Ludwig scientists worked on the biology that became checkpoint immunotherapy, on tumour antigens and on cancer genomics. Headquartered in New York with historic roots in Zurich.
Location
New York, US
Type
research institute
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#338 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking
- Ludwig Institute branches
- Ludwig Centers at six US institutions (since 2006)
- Cancer immunology and tumour antigens
- Cancer genomics and metabolism
Similar pages
- PersonDavid H. Koch
Shares David H. Koch Institute for Integrative Cancer Research at MIT, Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, The valley of death between lab and product, Funding follows fashion, not burden.
- CompanyBreak Through Cancer
Shares David H. Koch Institute for Integrative Cancer Research at MIT, Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center.
- PersonThomas F. Gajewski
Shares University of Chicago Medicine Comprehensive Cancer Center, Immune checkpoint inhibitors.
- PersonAlfred P. Sloan Jr.
Shares The valley of death between lab and product, Funding follows fashion, not burden, Memorial Sloan Kettering Cancer Center.
- PersonCharles F. Kettering
Shares The valley of death between lab and product, Funding follows fashion, not burden, Memorial Sloan Kettering Cancer Center.
- PersonSean Parker
Shares Stanford Health Care / Stanford Cancer Institute, Funding follows fashion, not burden, Memorial Sloan Kettering Cancer Center, Immune checkpoint inhibitors.
- PersonLeon Black
Shares The valley of death between lab and product, Funding follows fashion, not burden, Immune checkpoint inhibitors.
- PersonDavid B. Solit
Shares Memorial Sloan Kettering Cancer Center, Comprehensive genomic profiling.